Reduced levels of oestrogen receptor β mRNA in Swedish patients with chronic fatigue syndrome
- 1Department of Laboratory Medicine, Division of Clinical Bacteriology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
- 2Department of Biosciences and Nutrition, Karolinska Institutet at NOVUM, Stockholm, Sweden
- Correspondence to: M Nilsson Department of Biosciences and Nutrition, Karolinska Institutet at NOVUM, S-141 57 Huddinge, Stockholm, Sweden;
- Accepted 27 March 2006
- Published Online First 26 May 2006
Background: Chronic fatigue syndrome (CFS) is an illness with unknown aetiology and pathophysiology. The difference in incidence by sex observed for CFS indicates a role for oestrogen and oestrogen receptors in disease development. Furthermore, an immunomediated pathogenesis has been suggested for CFS, providing an additional connection to oestrogen, which displays immunomodular functions.
Aims: To investigate a possible association of oestrogen receptor (ER) mRNAs and two ERβ single-nucleotide polymorphisms (SNPs) with CFS.
Methods: Messenger RNA levels of ERα, ERβ wt and ERβ cx were investigated in peripheral blood mononuclear cells from 30 patients with CFS and 36 healthy controls by quantitative real-time polymerase chain reaction. Two ERβ SNPs were scored in the same material.
Results: The CFS group showed significantly lower mRNA expression levels of ERβ wt compared with the healthy control group. No differences were observed for ERα or ERβ cx between patients and controls. There were no significant differences in frequency for the investigated ERβ SNPs between cases and controls.
Conclusions: The reduced ERβ wt expression level observed in this study is consistent with an immune-mediated pathogenesis of CFS. Additionally, the observation that ERβ wt expression is decreased in CFS could provide an entry point to identify interesting, potentially disease-causing, candidate molecules for further study. A possible connection between oestrogen, oestrogen receptors and CFS should be evaluated further.
- CFS, chronic fatigue syndrome
- PBMC, peripheral blood mononuclear cell
- SNP, single-nucleotide polymorphism
↵* These authors contributed equally to this work.
Published online first 26 May 2006
Funding: This work was supported by the Swedish Research Council, the Swedish Cancer Fund, and the Swedish Council for Working Life and Social Research. MN was supported by the Golje Memory Foundation.
Competing interests: None.